 | • レポートコード：MRC2-11QY05740 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、115ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は酵素阻害剤のグローバル市場について調査・分析したレポートです。種類別（可逆的阻害剤、不可逆的阻害剤）市場規模、用途別（医薬品、農薬、食品・飲料、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別酵素阻害剤の競争状況、市場シェア ・世界の酵素阻害剤市場：種類別市場規模 2015年-2020年（可逆的阻害剤、不可逆的阻害剤） ・世界の酵素阻害剤市場：種類別市場規模予測 2021年-2026年（可逆的阻害剤、不可逆的阻害剤） ・世界の酵素阻害剤市場：用途別市場規模 2015年-2020年（医薬品、農薬、食品・飲料、その他） ・世界の酵素阻害剤市場：用途別市場規模予測 2021年-2026年（医薬品、農薬、食品・飲料、その他） ・北米の酵素阻害剤市場分析：米国、カナダ ・ヨーロッパの酵素阻害剤市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの酵素阻害剤市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の酵素阻害剤市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの酵素阻害剤市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：AstraZeneca、Merck、Novartis、Pfizer、Ranbaxy Laboratories、Roche-Genentech、Takeda Pharmaceuticals、Abbott Laboratories、Bayer、Johnson and Johnson ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Enzyme Inhibitor Market
The global Enzyme Inhibitor market size is projected to reach US$ 144980 million by 2026, from US$ 143750 million in 2020, at a CAGR of 0.8%% during 2021-2026.
Global Enzyme Inhibitor Scope and Market Size
Enzyme Inhibitor market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Enzyme Inhibitor market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Enzyme Inhibitor market is segmented into
Reversible Inhibitor
Irreversible Inhibitor
Segment by Application, the Enzyme Inhibitor market is segmented into
Pharmaceutical
Agrochemical
Food & Beverage
Others
Regional and Country-level Analysis
The Enzyme Inhibitor market is analysed and market size information is provided by regions (countries).
The key regions covered in the Enzyme Inhibitor market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Enzyme Inhibitor Market Share Analysis
Enzyme Inhibitor market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Enzyme Inhibitor business, the date to enter into the Enzyme Inhibitor market, Enzyme Inhibitor product introduction, recent developments, etc.
The major vendors covered:
AstraZeneca
Merck
Novartis
Pfizer
Ranbaxy Laboratories
Roche-Genentech
Takeda Pharmaceuticals
Abbott Laboratories
Bayer
Johnson and Johnson
1 Study Coverage
1.1 Enzyme Inhibitor Product Introduction
1.2 Market Segments
1.3 Key Enzyme Inhibitor Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Enzyme Inhibitor Market Size Growth Rate by Type
1.4.2 Reversible Inhibitor
1.4.3 Irreversible Inhibitor
1.5 Market by Application
1.5.1 Global Enzyme Inhibitor Market Size Growth Rate by Application
1.5.2 Pharmaceutical
1.5.3 Agrochemical
1.5.4 Food & Beverage
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Enzyme Inhibitor Market Size, Estimates and Forecasts
2.1.1 Global Enzyme Inhibitor Revenue 2015-2026
2.1.2 Global Enzyme Inhibitor Sales 2015-2026
2.2 Global Enzyme Inhibitor, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Enzyme Inhibitor Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Enzyme Inhibitor Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Enzyme Inhibitor Competitor Landscape by Players
3.1 Enzyme Inhibitor Sales by Manufacturers
3.1.1 Enzyme Inhibitor Sales by Manufacturers (2015-2020)
3.1.2 Enzyme Inhibitor Sales Market Share by Manufacturers (2015-2020)
3.2 Enzyme Inhibitor Revenue by Manufacturers
3.2.1 Enzyme Inhibitor Revenue by Manufacturers (2015-2020)
3.2.2 Enzyme Inhibitor Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Enzyme Inhibitor Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Enzyme Inhibitor Revenue in 2019
3.2.5 Global Enzyme Inhibitor Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Enzyme Inhibitor Price by Manufacturers
3.4 Enzyme Inhibitor Manufacturing Base Distribution, Product Types
3.4.1 Enzyme Inhibitor Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Enzyme Inhibitor Product Type
3.4.3 Date of International Manufacturers Enter into Enzyme Inhibitor Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Enzyme Inhibitor Market Size by Type (2015-2020)
4.1.1 Global Enzyme Inhibitor Sales by Type (2015-2020)
4.1.2 Global Enzyme Inhibitor Revenue by Type (2015-2020)
4.1.3 Enzyme Inhibitor Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Enzyme Inhibitor Market Size Forecast by Type (2021-2026)
4.2.1 Global Enzyme Inhibitor Sales Forecast by Type (2021-2026)
4.2.2 Global Enzyme Inhibitor Revenue Forecast by Type (2021-2026)
4.2.3 Enzyme Inhibitor Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Enzyme Inhibitor Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Enzyme Inhibitor Market Size by Application (2015-2020)
5.1.1 Global Enzyme Inhibitor Sales by Application (2015-2020)
5.1.2 Global Enzyme Inhibitor Revenue by Application (2015-2020)
5.1.3 Enzyme Inhibitor Price by Application (2015-2020)
5.2 Enzyme Inhibitor Market Size Forecast by Application (2021-2026)
5.2.1 Global Enzyme Inhibitor Sales Forecast by Application (2021-2026)
5.2.2 Global Enzyme Inhibitor Revenue Forecast by Application (2021-2026)
5.2.3 Global Enzyme Inhibitor Price Forecast by Application (2021-2026)
6 North America
6.1 North America Enzyme Inhibitor by Country
6.1.1 North America Enzyme Inhibitor Sales by Country
6.1.2 North America Enzyme Inhibitor Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Enzyme Inhibitor Market Facts & Figures by Type
6.3 North America Enzyme Inhibitor Market Facts & Figures by Application
7 Europe
7.1 Europe Enzyme Inhibitor by Country
7.1.1 Europe Enzyme Inhibitor Sales by Country
7.1.2 Europe Enzyme Inhibitor Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Enzyme Inhibitor Market Facts & Figures by Type
7.3 Europe Enzyme Inhibitor Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Enzyme Inhibitor by Region
8.1.1 Asia Pacific Enzyme Inhibitor Sales by Region
8.1.2 Asia Pacific Enzyme Inhibitor Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Enzyme Inhibitor Market Facts & Figures by Type
8.3 Asia Pacific Enzyme Inhibitor Market Facts & Figures by Application
9 Latin America
9.1 Latin America Enzyme Inhibitor by Country
9.1.1 Latin America Enzyme Inhibitor Sales by Country
9.1.2 Latin America Enzyme Inhibitor Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Enzyme Inhibitor Market Facts & Figures by Type
9.3 Central & South America Enzyme Inhibitor Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Enzyme Inhibitor by Country
10.1.1 Middle East and Africa Enzyme Inhibitor Sales by Country
10.1.2 Middle East and Africa Enzyme Inhibitor Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Enzyme Inhibitor Market Facts & Figures by Type
10.3 Middle East and Africa Enzyme Inhibitor Market Facts & Figures by Application
11 Company Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Corporation Information
11.1.2 AstraZeneca Description and Business Overview
11.1.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
11.1.4 AstraZeneca Enzyme Inhibitor Products Offered
11.1.5 AstraZeneca Related Developments
11.2 Merck
11.2.1 Merck Corporation Information
11.2.2 Merck Description and Business Overview
11.2.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Merck Enzyme Inhibitor Products Offered
11.2.5 Merck Related Developments
11.3 Novartis
11.3.1 Novartis Corporation Information
11.3.2 Novartis Description and Business Overview
11.3.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Novartis Enzyme Inhibitor Products Offered
11.3.5 Novartis Related Developments
11.4 Pfizer
11.4.1 Pfizer Corporation Information
11.4.2 Pfizer Description and Business Overview
11.4.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Pfizer Enzyme Inhibitor Products Offered
11.4.5 Pfizer Related Developments
11.5 Ranbaxy Laboratories
11.5.1 Ranbaxy Laboratories Corporation Information
11.5.2 Ranbaxy Laboratories Description and Business Overview
11.5.3 Ranbaxy Laboratories Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Ranbaxy Laboratories Enzyme Inhibitor Products Offered
11.5.5 Ranbaxy Laboratories Related Developments
11.6 Roche-Genentech
11.6.1 Roche-Genentech Corporation Information
11.6.2 Roche-Genentech Description and Business Overview
11.6.3 Roche-Genentech Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Roche-Genentech Enzyme Inhibitor Products Offered
11.6.5 Roche-Genentech Related Developments
11.7 Takeda Pharmaceuticals
11.7.1 Takeda Pharmaceuticals Corporation Information
11.7.2 Takeda Pharmaceuticals Description and Business Overview
11.7.3 Takeda Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Takeda Pharmaceuticals Enzyme Inhibitor Products Offered
11.7.5 Takeda Pharmaceuticals Related Developments
11.8 Abbott Laboratories
11.8.1 Abbott Laboratories Corporation Information
11.8.2 Abbott Laboratories Description and Business Overview
11.8.3 Abbott Laboratories Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Abbott Laboratories Enzyme Inhibitor Products Offered
11.8.5 Abbott Laboratories Related Developments
11.9 Bayer
11.9.1 Bayer Corporation Information
11.9.2 Bayer Description and Business Overview
11.9.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Bayer Enzyme Inhibitor Products Offered
11.9.5 Bayer Related Developments
11.10 Johnson and Johnson
11.10.1 Johnson and Johnson Corporation Information
11.10.2 Johnson and Johnson Description and Business Overview
11.10.3 Johnson and Johnson Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Johnson and Johnson Enzyme Inhibitor Products Offered
11.10.5 Johnson and Johnson Related Developments
11.1 AstraZeneca
11.1.1 AstraZeneca Corporation Information
11.1.2 AstraZeneca Description and Business Overview
11.1.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
11.1.4 AstraZeneca Enzyme Inhibitor Products Offered
11.1.5 AstraZeneca Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Enzyme Inhibitor Market Estimates and Projections by Region
12.1.1 Global Enzyme Inhibitor Sales Forecast by Regions 2021-2026
12.1.2 Global Enzyme Inhibitor Revenue Forecast by Regions 2021-2026
12.2 North America Enzyme Inhibitor Market Size Forecast (2021-2026)
12.2.1 North America: Enzyme Inhibitor Sales Forecast (2021-2026)
12.2.2 North America: Enzyme Inhibitor Revenue Forecast (2021-2026)
12.2.3 North America: Enzyme Inhibitor Market Size Forecast by Country (2021-2026)
12.3 Europe Enzyme Inhibitor Market Size Forecast (2021-2026)
12.3.1 Europe: Enzyme Inhibitor Sales Forecast (2021-2026)
12.3.2 Europe: Enzyme Inhibitor Revenue Forecast (2021-2026)
12.3.3 Europe: Enzyme Inhibitor Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Enzyme Inhibitor Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Enzyme Inhibitor Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Enzyme Inhibitor Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Enzyme Inhibitor Market Size Forecast by Region (2021-2026)
12.5 Latin America Enzyme Inhibitor Market Size Forecast (2021-2026)
12.5.1 Latin America: Enzyme Inhibitor Sales Forecast (2021-2026)
12.5.2 Latin America: Enzyme Inhibitor Revenue Forecast (2021-2026)
12.5.3 Latin America: Enzyme Inhibitor Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Enzyme Inhibitor Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Enzyme Inhibitor Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Enzyme Inhibitor Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Enzyme Inhibitor Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Enzyme Inhibitor Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Enzyme Inhibitor Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Enzyme Inhibitor Market Segments
Table 2. Ranking of Global Top Enzyme Inhibitor Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Enzyme Inhibitor Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Reversible Inhibitor
Table 5. Major Manufacturers of Irreversible Inhibitor
Table 6. Global Enzyme Inhibitor Market Size Growth Rate by Application 2020-2026 (K MT)
Table 7. Global Enzyme Inhibitor Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 8. Global Enzyme Inhibitor Sales by Regions 2015-2020 (K MT)
Table 9. Global Enzyme Inhibitor Sales Market Share by Regions (2015-2020)
Table 10. Global Enzyme Inhibitor Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Enzyme Inhibitor Sales by Manufacturers (2015-2020) (K MT)
Table 12. Global Enzyme Inhibitor Sales Share by Manufacturers (2015-2020)
Table 13. Global Enzyme Inhibitor Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 14. Global Enzyme Inhibitor by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Enzyme Inhibitor as of 2019)
Table 15. Enzyme Inhibitor Revenue by Manufacturers (2015-2020) (US$ Million)
Table 16. Enzyme Inhibitor Revenue Share by Manufacturers (2015-2020)
Table 17. Key Manufacturers Enzyme Inhibitor Price (2015-2020) (USD/MT)
Table 18. Enzyme Inhibitor Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Enzyme Inhibitor Product Type
Table 20. Date of International Manufacturers Enter into Enzyme Inhibitor Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Global Enzyme Inhibitor Sales by Type (2015-2020) (K MT)
Table 23. Global Enzyme Inhibitor Sales Share by Type (2015-2020)
Table 24. Global Enzyme Inhibitor Revenue by Type (2015-2020) (US$ Million)
Table 25. Global Enzyme Inhibitor Revenue Share by Type (2015-2020)
Table 26. Enzyme Inhibitor Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 27. Global Enzyme Inhibitor Sales by Application (2015-2020) (K MT)
Table 28. Global Enzyme Inhibitor Sales Share by Application (2015-2020)
Table 29. North America Enzyme Inhibitor Sales by Country (2015-2020) (K MT)
Table 30. North America Enzyme Inhibitor Sales Market Share by Country (2015-2020)
Table 31. North America Enzyme Inhibitor Revenue by Country (2015-2020) (US$ Million)
Table 32. North America Enzyme Inhibitor Revenue Market Share by Country (2015-2020)
Table 33. North America Enzyme Inhibitor Sales by Type (2015-2020) (K MT)
Table 34. North America Enzyme Inhibitor Sales Market Share by Type (2015-2020)
Table 35. North America Enzyme Inhibitor Sales by Application (2015-2020) (K MT)
Table 36. North America Enzyme Inhibitor Sales Market Share by Application (2015-2020)
Table 37. Europe Enzyme Inhibitor Sales by Country (2015-2020) (K MT)
Table 38. Europe Enzyme Inhibitor Sales Market Share by Country (2015-2020)
Table 39. Europe Enzyme Inhibitor Revenue by Country (2015-2020) (US$ Million)
Table 40. Europe Enzyme Inhibitor Revenue Market Share by Country (2015-2020)
Table 41. Europe Enzyme Inhibitor Sales by Type (2015-2020) (K MT)
Table 42. Europe Enzyme Inhibitor Sales Market Share by Type (2015-2020)
Table 43. Europe Enzyme Inhibitor Sales by Application (2015-2020) (K MT)
Table 44. Europe Enzyme Inhibitor Sales Market Share by Application (2015-2020)
Table 45. Asia Pacific Enzyme Inhibitor Sales by Region (2015-2020) (K MT)
Table 46. Asia Pacific Enzyme Inhibitor Sales Market Share by Region (2015-2020)
Table 47. Asia Pacific Enzyme Inhibitor Revenue by Region (2015-2020) (US$ Million)
Table 48. Asia Pacific Enzyme Inhibitor Revenue Market Share by Region (2015-2020)
Table 49. Asia Pacific Enzyme Inhibitor Sales by Type (2015-2020) (K MT)
Table 50. Asia Pacific Enzyme Inhibitor Sales Market Share by Type (2015-2020)
Table 51. Asia Pacific Enzyme Inhibitor Sales by Application (2015-2020) (K MT)
Table 52. Asia Pacific Enzyme Inhibitor Sales Market Share by Application (2015-2020)
Table 53. Latin America Enzyme Inhibitor Sales by Country (2015-2020) (K MT)
Table 54. Latin America Enzyme Inhibitor Sales Market Share by Country (2015-2020)
Table 55. Latin Americaa Enzyme Inhibitor Revenue by Country (2015-2020) (US$ Million)
Table 56. Latin America Enzyme Inhibitor Revenue Market Share by Country (2015-2020)
Table 57. Latin America Enzyme Inhibitor Sales by Type (2015-2020) (K MT)
Table 58. Latin America Enzyme Inhibitor Sales Market Share by Type (2015-2020)
Table 59. Latin America Enzyme Inhibitor Sales by Application (2015-2020) (K MT)
Table 60. Latin America Enzyme Inhibitor Sales Market Share by Application (2015-2020)
Table 61. Middle East and Africa Enzyme Inhibitor Sales by Country (2015-2020) (K MT)
Table 62. Middle East and Africa Enzyme Inhibitor Sales Market Share by Country (2015-2020)
Table 63. Middle East and Africa Enzyme Inhibitor Revenue by Country (2015-2020) (US$ Million)
Table 64. Middle East and Africa Enzyme Inhibitor Revenue Market Share by Country (2015-2020)
Table 65. Middle East and Africa Enzyme Inhibitor Sales by Type (2015-2020) (K MT)
Table 66. Middle East and Africa Enzyme Inhibitor Sales Market Share by Type (2015-2020)
Table 67. Middle East and Africa Enzyme Inhibitor Sales by Application (2015-2020) (K MT)
Table 68. Middle East and Africa Enzyme Inhibitor Sales Market Share by Application (2015-2020)
Table 69. AstraZeneca Corporation Information
Table 70. AstraZeneca Description and Major Businesses
Table 71. AstraZeneca Enzyme Inhibitor Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 72. AstraZeneca Product
Table 73. AstraZeneca Recent Development
Table 74. Merck Corporation Information
Table 75. Merck Description and Major Businesses
Table 76. Merck Enzyme Inhibitor Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 77. Merck Product
Table 78. Merck Recent Development
Table 79. Novartis Corporation Information
Table 80. Novartis Description and Major Businesses
Table 81. Novartis Enzyme Inhibitor Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 82. Novartis Product
Table 83. Novartis Recent Development
Table 84. Pfizer Corporation Information
Table 85. Pfizer Description and Major Businesses
Table 86. Pfizer Enzyme Inhibitor Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 87. Pfizer Product
Table 88. Pfizer Recent Development
Table 89. Ranbaxy Laboratories Corporation Information
Table 90. Ranbaxy Laboratories Description and Major Businesses
Table 91. Ranbaxy Laboratories Enzyme Inhibitor Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 92. Ranbaxy Laboratories Product
Table 93. Ranbaxy Laboratories Recent Development
Table 94. Roche-Genentech Corporation Information
Table 95. Roche-Genentech Description and Major Businesses
Table 96. Roche-Genentech Enzyme Inhibitor Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 97. Roche-Genentech Product
Table 98. Roche-Genentech Recent Development
Table 99. Takeda Pharmaceuticals Corporation Information
Table 100. Takeda Pharmaceuticals Description and Major Businesses
Table 101. Takeda Pharmaceuticals Enzyme Inhibitor Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 102. Takeda Pharmaceuticals Product
Table 103. Takeda Pharmaceuticals Recent Development
Table 104. Abbott Laboratories Corporation Information
Table 105. Abbott Laboratories Description and Major Businesses
Table 106. Abbott Laboratories Enzyme Inhibitor Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 107. Abbott Laboratories Product
Table 108. Abbott Laboratories Recent Development
Table 109. Bayer Corporation Information
Table 110. Bayer Description and Major Businesses
Table 111. Bayer Enzyme Inhibitor Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 112. Bayer Product
Table 113. Bayer Recent Development
Table 114. Johnson and Johnson Corporation Information
Table 115. Johnson and Johnson Description and Major Businesses
Table 116. Johnson and Johnson Enzyme Inhibitor Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 117. Johnson and Johnson Product
Table 118. Johnson and Johnson Recent Development
Table 119. Global Enzyme Inhibitor Sales Forecast by Regions (2021-2026) (K MT)
Table 120. Global Enzyme Inhibitor Sales Market Share Forecast by Regions (2021-2026)
Table 121. Global Enzyme Inhibitor Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 122. Global Enzyme Inhibitor Revenue Market Share Forecast by Regions (2021-2026)
Table 123. North America: Enzyme Inhibitor Sales Forecast by Country (2021-2026) (K MT)
Table 124. North America: Enzyme Inhibitor Revenue Forecast by Country (2021-2026) (US$ Million)
Table 125. Europe: Enzyme Inhibitor Sales Forecast by Country (2021-2026) (K MT)
Table 126. Europe: Enzyme Inhibitor Revenue Forecast by Country (2021-2026) (US$ Million)
Table 127. Asia Pacific: Enzyme Inhibitor Sales Forecast by Region (2021-2026) (K MT)
Table 128. Asia Pacific: Enzyme Inhibitor Revenue Forecast by Region (2021-2026) (US$ Million)
Table 129. Latin America: Enzyme Inhibitor Sales Forecast by Country (2021-2026) (K MT)
Table 130. Latin America: Enzyme Inhibitor Revenue Forecast by Country (2021-2026) (US$ Million)
Table 131. Middle East and Africa: Enzyme Inhibitor Sales Forecast by Country (2021-2026) (K MT)
Table 132. Middle East and Africa: Enzyme Inhibitor Revenue Forecast by Country (2021-2026) (US$ Million)
Table 133. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 134. Key Challenges
Table 135. Market Risks
Table 136. Main Points Interviewed from Key Enzyme Inhibitor Players
Table 137. Enzyme Inhibitor Customers List
Table 138. Enzyme Inhibitor Distributors List
Table 139. Research Programs/Design for This Report
Table 140. Key Data Information from Secondary Sources
Table 141. Key Data Information from Primary Sources
List of Figures
Figure 1. Enzyme Inhibitor Product Picture
Figure 2. Global Enzyme Inhibitor Sales Market Share by Type in 2020 & 2026
Figure 3. Reversible Inhibitor Product Picture
Figure 4. Irreversible Inhibitor Product Picture
Figure 5. Global Enzyme Inhibitor Sales Market Share by Application in 2020 & 2026
Figure 6. Pharmaceutical
Figure 7. Agrochemical
Figure 8. Food & Beverage
Figure 9. Others
Figure 10. Enzyme Inhibitor Report Years Considered
Figure 11. Global Enzyme Inhibitor Market Size 2015-2026 (US$ Million)
Figure 12. Global Enzyme Inhibitor Sales 2015-2026 (K MT)
Figure 13. Global Enzyme Inhibitor Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global Enzyme Inhibitor Sales Market Share by Region (2015-2020)
Figure 15. Global Enzyme Inhibitor Sales Market Share by Region in 2019
Figure 16. Global Enzyme Inhibitor Revenue Market Share by Region (2015-2020)
Figure 17. Global Enzyme Inhibitor Revenue Market Share by Region in 2019
Figure 18. Global Enzyme Inhibitor Sales Share by Manufacturer in 2019
Figure 19. The Top 10 and 5 Players Market Share by Enzyme Inhibitor Revenue in 2019
Figure 20. Enzyme Inhibitor Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Enzyme Inhibitor Sales Market Share by Type (2015-2020)
Figure 22. Global Enzyme Inhibitor Sales Market Share by Type in 2019
Figure 23. Global Enzyme Inhibitor Revenue Market Share by Type (2015-2020)
Figure 24. Global Enzyme Inhibitor Revenue Market Share by Type in 2019
Figure 25. Global Enzyme Inhibitor Market Share by Price Range (2015-2020)
Figure 26. Global Enzyme Inhibitor Sales Market Share by Application (2015-2020)
Figure 27. Global Enzyme Inhibitor Sales Market Share by Application in 2019
Figure 28. Global Enzyme Inhibitor Revenue Market Share by Application (2015-2020)
Figure 29. Global Enzyme Inhibitor Revenue Market Share by Application in 2019
Figure 30. North America Enzyme Inhibitor Sales Growth Rate 2015-2020 (K MT)
Figure 31. North America Enzyme Inhibitor Revenue Growth Rate 2015-2020 (US$ Million)
Figure 32. North America Enzyme Inhibitor Sales Market Share by Country in 2019
Figure 33. North America Enzyme Inhibitor Revenue Market Share by Country in 2019
Figure 34. U.S. Enzyme Inhibitor Sales Growth Rate (2015-2020) (K MT)
Figure 35. U.S. Enzyme Inhibitor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Canada Enzyme Inhibitor Sales Growth Rate (2015-2020) (K MT)
Figure 37. Canada Enzyme Inhibitor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. North America Enzyme Inhibitor Market Share by Type in 2019
Figure 39. North America Enzyme Inhibitor Market Share by Application in 2019
Figure 40. Europe Enzyme Inhibitor Sales Growth Rate 2015-2020 (K MT)
Figure 41. Europe Enzyme Inhibitor Revenue Growth Rate 2015-2020 (US$ Million)
Figure 42. Europe Enzyme Inhibitor Sales Market Share by Country in 2019
Figure 43. Europe Enzyme Inhibitor Revenue Market Share by Country in 2019
Figure 44. Germany Enzyme Inhibitor Sales Growth Rate (2015-2020) (K MT)
Figure 45. Germany Enzyme Inhibitor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. France Enzyme Inhibitor Sales Growth Rate (2015-2020) (K MT)
Figure 47. France Enzyme Inhibitor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. U.K. Enzyme Inhibitor Sales Growth Rate (2015-2020) (K MT)
Figure 49. U.K. Enzyme Inhibitor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Italy Enzyme Inhibitor Sales Growth Rate (2015-2020) (K MT)
Figure 51. Italy Enzyme Inhibitor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Russia Enzyme Inhibitor Sales Growth Rate (2015-2020) (K MT)
Figure 53. Russia Enzyme Inhibitor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Europe Enzyme Inhibitor Market Share by Type in 2019
Figure 55. Europe Enzyme Inhibitor Market Share by Application in 2019
Figure 56. Asia Pacific Enzyme Inhibitor Sales Growth Rate 2015-2020 (K MT)
Figure 57. Asia Pacific Enzyme Inhibitor Revenue Growth Rate 2015-2020 (US$ Million)
Figure 58. Asia Pacific Enzyme Inhibitor Sales Market Share by Region in 2019
Figure 59. Asia Pacific Enzyme Inhibitor Revenue Market Share by Region in 2019
Figure 60. China Enzyme Inhibitor Sales Growth Rate (2015-2020) (K MT)
Figure 61. China Enzyme Inhibitor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Japan Enzyme Inhibitor Sales Growth Rate (2015-2020) (K MT)
Figure 63. Japan Enzyme Inhibitor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. South Korea Enzyme Inhibitor Sales Growth Rate (2015-2020) (K MT)
Figure 65. South Korea Enzyme Inhibitor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. India Enzyme Inhibitor Sales Growth Rate (2015-2020) (K MT)
Figure 67. India Enzyme Inhibitor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Australia Enzyme Inhibitor Sales Growth Rate (2015-2020) (K MT)
Figure 69. Australia Enzyme Inhibitor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Taiwan Enzyme Inhibitor Sales Growth Rate (2015-2020) (K MT)
Figure 71. Taiwan Enzyme Inhibitor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Indonesia Enzyme Inhibitor Sales Growth Rate (2015-2020) (K MT)
Figure 73. Indonesia Enzyme Inhibitor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Thailand Enzyme Inhibitor Sales Growth Rate (2015-2020) (K MT)
Figure 75. Thailand Enzyme Inhibitor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Malaysia Enzyme Inhibitor Sales Growth Rate (2015-2020) (K MT)
Figure 77. Malaysia Enzyme Inhibitor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Philippines Enzyme Inhibitor Sales Growth Rate (2015-2020) (K MT)
Figure 79. Philippines Enzyme Inhibitor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Vietnam Enzyme Inhibitor Sales Growth Rate (2015-2020) (K MT)
Figure 81. Vietnam Enzyme Inhibitor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Asia Pacific Enzyme Inhibitor Market Share by Type in 2019
Figure 83. Asia Pacific Enzyme Inhibitor Market Share by Application in 2019
Figure 84. Latin America Enzyme Inhibitor Sales Growth Rate 2015-2020 (K MT)
Figure 85. Latin America Enzyme Inhibitor Revenue Growth Rate 2015-2020 (US$ Million)
Figure 86. Latin America Enzyme Inhibitor Sales Market Share by Country in 2019
Figure 87. Latin America Enzyme Inhibitor Revenue Market Share by Country in 2019
Figure 88. Mexico Enzyme Inhibitor Sales Growth Rate (2015-2020) (K MT)
Figure 89. Mexico Enzyme Inhibitor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Brazil Enzyme Inhibitor Sales Growth Rate (2015-2020) (K MT)
Figure 91. Brazil Enzyme Inhibitor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Argentina Enzyme Inhibitor Sales Growth Rate (2015-2020) (K MT)
Figure 93. Argentina Enzyme Inhibitor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Latin America Enzyme Inhibitor Market Share by Type in 2019
Figure 95. Latin America Enzyme Inhibitor Market Share by Application in 2019
Figure 96. Middle East and Africa Enzyme Inhibitor Sales Growth Rate 2015-2020 (K MT)
Figure 97. Middle East and Africa Enzyme Inhibitor Revenue Growth Rate 2015-2020 (US$ Million)
Figure 98. Middle East and Africa Enzyme Inhibitor Sales Market Share by Country in 2019
Figure 99. Middle East and Africa Enzyme Inhibitor Revenue Market Share by Country in 2019
Figure 100. Turkey Enzyme Inhibitor Sales Growth Rate (2015-2020) (K MT)
Figure 101. Turkey Enzyme Inhibitor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. Saudi Arabia Enzyme Inhibitor Sales Growth Rate (2015-2020) (K MT)
Figure 103. Saudi Arabia Enzyme Inhibitor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. U.A.E Enzyme Inhibitor Sales Growth Rate (2015-2020) (K MT)
Figure 105. U.A.E Enzyme Inhibitor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Middle East and Africa Enzyme Inhibitor Market Share by Type in 2019
Figure 107. Middle East and Africa Enzyme Inhibitor Market Share by Application in 2019
Figure 108. North America Enzyme Inhibitor Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 109. North America Enzyme Inhibitor Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 110. Europe Enzyme Inhibitor Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 111. Europe Enzyme Inhibitor Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Asia Pacific Enzyme Inhibitor Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 113. Asia Pacific Enzyme Inhibitor Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Latin America Enzyme Inhibitor Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 115. Latin America Enzyme Inhibitor Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Middle East and Africa Enzyme Inhibitor Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 117. Middle East and Africa Enzyme Inhibitor Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Porter's Five Forces Analysis
Figure 119. Channels of Distribution
Figure 120. Distributors Profiles
Figure 121. Bottom-up and Top-down Approaches for This Report
Figure 122. Data Triangulation
Figure 123. Key Executives Interviewed
血漿プロテアーゼC1阻害剤治療の世界市場（～2026年） This report on the plasma protease C1-inhibitors treatment market analyzes the current and future scenario of the global market. Large number of acute HAE patients is increasing the usage of plasma protease C1-inhibitors treatment. Increasing prevalence of rare diseases around the world, promising p…- プラスミノーゲンアクチベーター阻害剤1の世界市場（～2026年） Market Analysis and Insights: Global Plasminogen Activator Inhibitor 1 Market The global Plasminogen Activator Inhibitor 1 market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Plasminogen Activator Inhibitor 1 Scope and Mar…
- IDO阻害剤の世界市場（～2026年） Market Analysis and Insights: Global IDO inhibitor Market The global IDO inhibitor market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global IDO inhibitor Scope and Market Size IDO inhibitor market is segmented by Type, and by A…
- α1プロテアーゼインヒビターの世界市場（～2026年） Market Analysis and Insights: Global Alpha1-Proteinase Inhibitor Market The global Alpha1-Proteinase Inhibitor market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Alpha1-Proteinase Inhibitor Scope and Market Size Alpha1-Pr…
- 油田スケール抑制剤の世界市場（～2026年） Oilfield scale inhibition is the process of preventing the formation of scale from blocking or hindering fluid flow through pipelines, valves, and pumps used in oil production and processing. Scale inhibitors (SIs) are a class of specialty chemicals that are used to slow or prevent scaling in water …